Guardant Health Inc
(NAS:GH)
$
23.45
-0.15 (-0.64%)
Market Cap: 2.88 Bil
Enterprise Value: 3.22 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 69/100 Guardant Health Inc at UBS Genomics 2.0 and Medtech Innovations Summit (Virtual) Transcript
Aug 11, 2020 / 04:00PM GMT
Release Date Price:
$81.62
(-5.00%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Great. Welcome, day 1 of the UBS Genomics 2.0 and Medtech Innovations Conference. This is Dan Brennan. I cover tools, diagnostics and pharma services.
I'm really pleased to be joined with me here at our 12:00 session with Helmy Eltoukhy, who I'm sure everyone knows very well, CEO of Guardant Health. So Helmy, thank you very much for participating.
Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, CEO & Director
Yes. Thank you, Dan, for having me.
Questions & Answers
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
That's terrific. Great. So obviously, a lot of great things to talk about. I got a lot of questions, which I'll try, I won't be able to get to all of them. So hopefully, I'll jump around and get the key points. Feel free for those on the phone to shoot me your question, I'll try to get
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot